8-142176399-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000584349.1(MIR4472-1):​n.61G>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.217 in 154,140 control chromosomes in the GnomAD database, including 5,534 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.22 ( 5515 hom., cov: 32)
Exomes 𝑓: 0.094 ( 19 hom. )

Consequence

MIR4472-1
ENST00000584349.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.984

Publications

12 publications found
Variant links:
Genes affected
MIR4472-1 (HGNC:41644): (microRNA 4472-1) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.453 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MIR4472-1NR_039682.1 linkn.61G>C non_coding_transcript_exon_variant Exon 1 of 1
MIR4472-1unassigned_transcript_1547 n.4G>C non_coding_transcript_exon_variant Exon 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MIR4472-1ENST00000584349.1 linkn.61G>C non_coding_transcript_exon_variant Exon 1 of 1 6
ENSG00000287332ENST00000662748.1 linkn.366+8763C>G intron_variant Intron 1 of 1
ENSG00000287332ENST00000748267.1 linkn.669+8763C>G intron_variant Intron 2 of 5
ENSG00000287332ENST00000748268.1 linkn.712+8763C>G intron_variant Intron 2 of 4

Frequencies

GnomAD3 genomes
AF:
0.219
AC:
33211
AN:
151838
Hom.:
5502
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.459
Gnomad AMI
AF:
0.0956
Gnomad AMR
AF:
0.239
Gnomad ASJ
AF:
0.107
Gnomad EAS
AF:
0.168
Gnomad SAS
AF:
0.144
Gnomad FIN
AF:
0.119
Gnomad MID
AF:
0.111
Gnomad NFE
AF:
0.102
Gnomad OTH
AF:
0.171
GnomAD2 exomes
AF:
0.0939
AC:
34
AN:
362
AF XY:
0.0941
show subpopulations
Gnomad AFR exome
AF:
0.500
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0954
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0939
AC:
205
AN:
2184
Hom.:
19
Cov.:
0
AF XY:
0.106
AC XY:
116
AN XY:
1092
show subpopulations
African (AFR)
AF:
0.419
AC:
31
AN:
74
American (AMR)
AF:
0.375
AC:
3
AN:
8
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
4
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AF:
0.0909
AC:
8
AN:
88
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
2
Middle Eastern (MID)
AF:
0.0651
AC:
106
AN:
1628
European-Non Finnish (NFE)
AF:
0.106
AC:
20
AN:
188
Other (OTH)
AF:
0.193
AC:
37
AN:
192
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
7
14
22
29
36
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.219
AC:
33271
AN:
151956
Hom.:
5515
Cov.:
32
AF XY:
0.219
AC XY:
16248
AN XY:
74318
show subpopulations
African (AFR)
AF:
0.459
AC:
18989
AN:
41392
American (AMR)
AF:
0.239
AC:
3655
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.107
AC:
371
AN:
3468
East Asian (EAS)
AF:
0.168
AC:
870
AN:
5164
South Asian (SAS)
AF:
0.143
AC:
683
AN:
4788
European-Finnish (FIN)
AF:
0.119
AC:
1265
AN:
10598
Middle Eastern (MID)
AF:
0.112
AC:
33
AN:
294
European-Non Finnish (NFE)
AF:
0.102
AC:
6959
AN:
67952
Other (OTH)
AF:
0.170
AC:
359
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1123
2247
3370
4494
5617
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
316
632
948
1264
1580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0849
Hom.:
150
Bravo
AF:
0.236
Asia WGS
AF:
0.177
AC:
614
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
2.7
DANN
Benign
0.74
PhyloP100
0.98

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28655823; hg19: chr8-143257760; API